New Market Study, "Czech Republic Pharmaceuticals & Healthcare Report Q4 2014", Has Been Published
The pharmaceutical supply chain within the Czech Republic has undergone a period of flux over the last decade. The pharmaceutical market itself, originally dominated by domestic and regional generic companies, has been won over by larger multinationals with competitive pressures expected to continue to favour those with scale. While we expect the Czech market to stabilise in 2014, we note that depreciatory pressure on the Czech koruna could see incomes decline for multinationals that operate within the Czech Republic. In...
View full press release